drugset / Trial / NCT01307033
A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351)
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is being conducted to evaluate the safety of MK-0954A (L100/H12.5 mg) in essential hypertension participants who are uncontrolled with MK-954H (L50/H12.5 mg).
Timeline
- Start
- 2011-03-29
- Primary completion
- 2012-12-04
- Completion
- 2012-12-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Losartan | Other / unclassified | 50 mg | Oral |
| Subject | Losartan | Other / unclassified | 100 mg | Oral |
| Background | Hydrochlorothiazide | Unknown | 12.5 mg | Oral |